サマリー

世界のインターベンショナルカーディオロジーおよび末梢血管デバイスの市場規模は、2020年に179億6080万ドルとなり、2021年から2030年にかけて年平均成長率8.5%を記録し、2030年には419億30万ドルに達すると予測されています。インターベンショナル・カーディオロジーは、カテーテルを用いた技術による治療に重点を置く心臓病学の一分野です。
インターベンショナル・カーディオロジーおよび末梢血管用デバイスは、通常、バルーン、カテーテル、ガイドワイヤー、ステント、フィルターで構成されています。これらの機器は、循環器系に影響を与え、腕や脚の動脈にプラークが蓄積する末梢血管障害の治療に使用されます。
高齢者人口の増加やライフスタイルの変化により、さまざまな心血管疾患に罹患する患者数が大幅に増加しています。このため、さまざまな心血管疾患を効果的に治療できる機器の需要が高まり、市場の成長にプラスの影響を及ぼしています。しかし、治療費の高騰や、インターベンショナル・カーディオロジーおよび末梢血管用デバイスの承認に関する厳格な規則などの要因が、市場の成長を抑制する可能性があります。さらに、発展途上国における医療インフラの急速な発展は、投資の増加に後押しされ、市場に有利な成長機会を提供しています。
製品別では、血管形成術バルーン、血管形成術ステント、血管形成術カテーテル、血管内動脈瘤修復ステントグラフト、下大静脈フィルター、プラーク修正装置、血行動態改善装置、アクセサリに分類されます。エンドユーザー別では、病院、外来手術センター、その他に区分されます。地域別では、北米、ヨーロッパ、アジア太平洋地域、LAMEAに分析されます。
世界市場で活動する主要企業は、市場への働きかけを強化し、市場での厳しい競争を維持するために、製品発売などの主要戦略を採用しています。
競合分析
本レポートで紹介する主な市場参加者は、Abbott Laboratories、B. Braun Melsungen AG、Becton, Dickinson and Company、Biotronik SE & Co.KG、Boston Scientific Corp.、Cardinal Health Inc.、Cook Medical、Koninklijke Philips N.V.、Medtronic plc、Terumo Corporationが含まれます。
ステークホルダーにとっての主なメリット
本レポートは、インターベンショナル・カーディオロジーおよび末梢血管デバイス市場の現在および新興のトレンドとダイナミクスについて広範な分析を提供します。
2020年から2030年までの主要な市場セグメントの市場推定を構築し、詳細な市場分析を実施します。
インターベンショナルカーディオロジーと末梢血管デバイス市場の広範な分析は、主要製品のポジショニングと市場フレームワーク内での上位競合企業のモニタリングを行うことによって実施されます。
全地域の包括的な分析は、優勢な機会を決定するために提供されます。
2021年から2030年までの世界のインターベンショナルカーディオロジーと末梢血管デバイスの市場予測分析が含まれています。
インターベンショナルカーディオロジーと末梢血管デバイス市場内の主要な市場プレイヤーを本レポートでプロファイルし、その戦略を徹底的に分析することで、インターベンショナルカーディオロジーと末梢血管デバイス業界の競争展望を理解するのに役立てることができます。

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Angioplasty Balloons
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Angioplasty Stents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Angioplasty Catheters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Endovascular Aneurysm Repair Stent Grafts
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Inferior Vena Cava (IVC) Filters
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Plaque Modification Devices
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Hemodynamic Flow Alteration Devices
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Accessories
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
CHAPTER 5: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ambulatory Surgical Centers
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Type
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Type
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Type
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Type
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Type
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Type
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Type
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Type
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Type
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Type
6.3.4.5.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Type
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Type
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Type
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Type
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 Australia
6.4.4.4.1 Market size and forecast, by Type
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 Rest Of Asia Pacific
6.4.4.5.1 Market size and forecast, by Type
6.4.4.5.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Type
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Type
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Type
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Type
6.5.4.3.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 B. Braun Melsungen AG
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Becton, Dickinson and Company.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Cardinal Health Inc.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Cook Group
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Medtronic plc
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Terumo Group
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Koninklijke Philips N.V.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Biotronik SE & Co. KG
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 2. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY BALLOONS, BY REGION , 2020-2030,($MILLION)
TABLE 3. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY BALLOONS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY STENTS, BY REGION , 2020-2030,($MILLION)
TABLE 5. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY STENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY CATHETERS, BY REGION , 2020-2030,($MILLION)
TABLE 7. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY CATHETERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION , 2020-2030,($MILLION)
TABLE 9. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION , 2020-2030,($MILLION)
TABLE 11. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET INFERIOR VENA CAVA (IVC) FILTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR PLAQUE MODIFICATION DEVICES, BY REGION , 2020-2030,($MILLION)
TABLE 13. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION , 2020-2030,($MILLION)
TABLE 15. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ACCESSORIES, BY REGION , 2020-2030,($MILLION)
TABLE 17. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ACCESSORIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 19. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 20. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
TABLE 22. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 24. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 30. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 31. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 32. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 33. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 34. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 35. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 36. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 37. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 38. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 39. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 40. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 41. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 42. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 43. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 44. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 45. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 46. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 47. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 48. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 49. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 50. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 51. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 52. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 53. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 54. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 56. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 57. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 58. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 59. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 60. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 61. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 62. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 63. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 64. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 65. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 66. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 67. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 68. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
TABLE 69. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
TABLE 70.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 71.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 72.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 73.ABBOTT LABORATORIES: NET SALES,
TABLE 74.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 75.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 76.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 77.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 78.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 79.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 80.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 81.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 82.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 83.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 84.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 85.BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT
TABLE 86.BECTON, DICKINSON AND COMPANY.: OPERATING SEGMENTS
TABLE 87.BECTON, DICKINSON AND COMPANY.: PRODUCT PORTFOLIO
TABLE 88.BECTON, DICKINSON AND COMPANY.: NET SALES,
TABLE 89.BECTON, DICKINSON AND COMPANY.: KEY STRATERGIES
TABLE 90.CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 91.CARDINAL HEALTH INC.: OPERATING SEGMENTS
TABLE 92.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
TABLE 93.CARDINAL HEALTH INC.: NET SALES,
TABLE 94.CARDINAL HEALTH INC.: KEY STRATERGIES
TABLE 95.COOK GROUP: COMPANY SNAPSHOT
TABLE 96.COOK GROUP: OPERATING SEGMENTS
TABLE 97.COOK GROUP: PRODUCT PORTFOLIO
TABLE 98.COOK GROUP: NET SALES,
TABLE 99.COOK GROUP: KEY STRATERGIES
TABLE 100.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 101.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 102.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 103.MEDTRONIC PLC: NET SALES,
TABLE 104.MEDTRONIC PLC: KEY STRATERGIES
TABLE 105.TERUMO GROUP: COMPANY SNAPSHOT
TABLE 106.TERUMO GROUP: OPERATING SEGMENTS
TABLE 107.TERUMO GROUP: PRODUCT PORTFOLIO
TABLE 108.TERUMO GROUP: NET SALES,
TABLE 109.TERUMO GROUP: KEY STRATERGIES
TABLE 110.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 111.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 112.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 113.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 114.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 115.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 116.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
TABLE 117.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 118.BIOTRONIK SE & CO. KG: NET SALES,
TABLE 119.BIOTRONIK SE & CO. KG: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
FIGURE 2.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
FIGURE 3.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY BALLOONS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY STENTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY CATHETERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INFERIOR VENA CAVA (IVC) FILTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PLAQUE MODIFICATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HEMODYNAMIC FLOW ALTERATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 20.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY END USER,2020(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
FIGURE 24.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY REGION,2020
FIGURE 25.U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 26.CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 27.MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 28.GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 29.FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 30.U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 31.SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 32.REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 33.CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 35.INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 36.AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 37.REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 38.LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 39.MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 40.AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 45.COMPETITIVE DASHBOARD
FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 47.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 48.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
FIGURE 49.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 50.BECTON, DICKINSON AND COMPANY..: NET SALES ,($MILLION)
FIGURE 51.CARDINAL HEALTH INC..: NET SALES ,($MILLION)
FIGURE 52.COOK GROUP.: NET SALES ,($MILLION)
FIGURE 53.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 54.TERUMO GROUP.: NET SALES ,($MILLION)
FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 56.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)